Yield10 Bioscience Inc

NASDAQ: YTEN    
Share price (5/3/24): $5.60    
Market cap (5/3/24): $79.4 million

Underwriting Agreements Filter

EX-1.1
from S-1/A 9 pages Confidential
12/34/56
EX-1.1
from 8-K 39 pages Yield10 Bioscience, Inc. Up to $4,200,000 of Common Stock Equity Distribution Agreement
12/34/56
EX-1.1
from 8-K 40 pages Yield10 Bioscience, Inc. Underwriting Agreement
12/34/56
EX-1.1
from 8-K 41 pages Yield10 Bioscience, Inc. Underwriting Agreement
12/34/56
EX-1.1
from 8-K 40 pages 12,480,000 Shares of Common Stock, 2,504 Shares of Series a Convertible Preferred Stock (Convertible Into 12,520,000 Shares of Common Stock), Warrants Exercisable Into 50,000,000 Shares of Common Stock of Yield10 Bioscience, Inc. Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 44 pages Shares of Common Stock Shares of Series a Convertible Preferred Stock (Convertible Into Shares of Common Stock), Warrants Exercisable Into Shares of Common Stock of Yield10 Bioscience, Inc. Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 44 pages Shares of Common Stock Shares of Series a Convertible Preferred Stock (Convertible Into Shares of Common Stock), Warrants Exercisable Into Shares of Common Stock of Yield10 Bioscience, Inc. Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 44 pages Shares of Common Stock, Shares of Series a Convertible Preferred Stock (Convertible Into Shares of Common Stock), Warrants Exercisable Into Shares of Common Stock of Yield10 Bioscience, Inc. Underwriting Agreement
12/34/56
EX-1.1
from 8-K 14 pages Placement Agency Agreement March 14, 2019
12/34/56
EX-1.1
from 8-K 41 pages 3,828,000 Shares of Common Stock, 3,987 Shares of Series a Convertible Preferred Stock (Convertible Into 1,774,215 Shares of Common Stock), Series a Warrants Exercisable Into 5,602,215 Shares of Common Stock and Series B Warrants Exercisable Into 2,803,101 Shares of Common Stock of Yield10 Bioscience, Inc. Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 41 pages Shares of Common Stock, Shares of Series a Convertible Preferred Stock (Convertible Into Shares of Common Stock), Series a Warrants Exercisable Into Shares of Common Stock and Series B Warrants Exercisable Into Shares of Common Stock of Yield10 Bioscience, Inc. Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 40 pages Exhibit 1.1 Shares of Common Stock, Shares of Series a Convertible Preferred Stock (Convertible Into Shares of Common Stock) and Warrants Exercisable Into Shares of Common Stock of Yield10 Bioscience, Inc. Underwriting Agreement December , 2017 Ladenburg Thalmann & Co. Inc. as the Representative of the Several Underwriters, if Any, Named in Schedule I Hereto 4400 Biscayne Boulevard, 14th Floor Miami, Florida 33137 Ladies and Gentlemen: The Undersigned, Yield10 Bioscience, Inc., a Company Incorporated Under the Laws of Delaware (Collectively With Its Subsidiaries and Affiliates, Including, Without Limitation, All Entities Disclosed or Described in the Registration Statement as Being Subsidiaries or Affiliates of Yield10 Bioscience, Inc., the “Company”), Hereby Confirms Its Agreement (This “Agreement”) With the Several Underwriters (Such Underwriters, Including the Representative (As Defined Below), the “Underwriters” and Each an “Underwriter”) Named in Schedule I Hereto for Which Ladenburg Thalmann & Co. Inc. Is Acting as Representative to the Several Underwriters (The “Representative” and if There Are No Underwriters Other Than the Representative, References to Multiple Underwriters Shall Be Disregarded and the Term Representative as Used Herein Shall Have the Same Meaning as Underwriter) on the Terms and Conditions Set Forth Herein. It Is Understood That the Several Underwriters Are to Make a Public Offering of the Public Securities as Soon as the Representative Deems It Advisable to Do So. the Public Securities Are to Be Initially Offered to the Public at the Public Offering Price Set Forth in the Prospectus. the Representative May From Time to Time Thereafter Change the Public Offering Price and Other Selling Terms. It Is Further Understood That You Will Act as the Representative for the Underwriters in the Offering and Sale of the Closing Securities And, if Any, the Option Securities in Accordance With This Agreement
12/34/56
EX-1.1
from S-1/A 40 pages Shares of Common Stock, Shares of Series a Convertible Preferred Stock (Convertible Into Shares of Common Stock) and Warrants Exercisable Into Shares of Common Stock of Yield10 Bioscience, Inc. Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 40 pages Shares of Common Stock, Shares of Series a Convertible Preferred Stock (Convertible Into Shares of Common Stock) and Warrants Exercisable Into Shares of Common Stock of Yield10 Bioscience, Inc. Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 40 pages Shares of Common Stock, Shares of Series a Convertible Preferred Stock (Convertible Into Shares of Common Stock) and Warrants Exercisable Into Shares of Common Stock of Yield10 Bioscience, Inc. Underwriting Agreement
12/34/56
EX-1
from SC 13D ~5 pages Amended and Restated Joint Filing Agreement
12/34/56
EX-1.1
from 8-K 15 pages Placement Agency Agreement July 3, 2017
12/34/56
EX-1.1
from 8-K 29 pages Metabolix, Inc. 6,200,000 Shares of Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 40 pages 3,000,000 Shares Metabolix, Inc. Common Stock Underwriting Agreement
12/34/56
EX-1.1
from S-1/A ~50 pages Underwriting agreement
12/34/56